Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 17,613 | 15,209 | 14,689 | 6,146 | 4,400 |
| Cost of Goods | 0 | 0 | 20,054 | 7,265 | 3,104 |
| Gross Profit | 17,613 | 15,209 | -5,365 | -1,119 | 1,296 |
| Operating Expenses | 25,965 | 20,418 | 2,707 | 2,262 | 1,376 |
| Operating Income | -8,352 | -5,209 | -8,018 | -3,116 | 24 |
| Interest Expense | 1 | 7 | 25 | 44 | 57 |
| Other Income | 0 | 0 | 2,110 | 2,240 | 338 |
| Pre-tax Income | -8,353 | -5,216 | -5,933 | -921 | 305 |
| Net Income Continuous | -8,354 | -5,216 | -5,933 | -921 | 305 |
| Net Income | $-8,353 | $-5,216 | $-5,933 | $-921 | $305 |
| EPS Basic Total Ops | -0.14 | -0.09 | -0.12 | -0.02 | 0.01 |
| EPS Basic Continuous Ops | -0.14 | -0.09 | -0.11 | -0.02 | 0.02 |
| EPS Diluted Total Ops | -0.14 | -0.09 | -0.12 | -0.02 | 0.02 |
| EPS Diluted Continuous Ops | -0.14 | -0.09 | -0.11 | -0.02 | 0.02 |
| EBITDA(a) | $-5,819 | $-3,044 | $-6,714 | $-2,493 | $272 |